Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators MD Berry Journal of neurochemistry 90 (2), 257-271, 2004 | 437 | 2004 |
Apoptotic signaling cascades PC Ashe, MD Berry Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (2), 199-214, 2003 | 313 | 2003 |
Trace amines and their receptors RR Gainetdinov, MC Hoener, MD Berry Pharmacological Reviews 70 (3), 549-620, 2018 | 310 | 2018 |
The functional role of monoamine oxidases A and B in the mammalian central nervous system MD Berry, AV Juorio, IA Paterson Progress in neurobiology 42 (3), 375-391, 1994 | 229 | 1994 |
Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges MD Berry, RR Gainetdinov, MC Hoener, M Shahid Pharmacology & therapeutics 180, 161-180, 2017 | 214 | 2017 |
Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents PC Ashe, MD Berry, AA Boulton Progress in Neuro-Psychopharmacology and Biological Psychiatry 25 (4), 691-707, 2001 | 163 | 2001 |
Glyceraldehyde‐3‐phosphate dehydrogenase and apoptosis MD Berry, AA Boulton Journal of neuroscience research 60 (2), 150-154, 2000 | 160 | 2000 |
Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme MD Berry, AV Juorio, XM Li, AA Boulton Neurochemical research 21, 1075-1087, 1996 | 150 | 1996 |
The potential of trace amines and their receptors for treating neurological and psychiatric diseases MD Berry Reviews on recent clinical trials 2 (1), 3-19, 2007 | 144 | 2007 |
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. IA Paterson, AV Juorio, MD Berry, MY Zhu Journal of Pharmacology and Experimental Therapeutics 258 (3), 1019-1026, 1991 | 99 | 1991 |
Possible mechanisms of action of (−) deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders MD Berry, AV Juorio, IA Paterson Progress in neurobiology 44 (2), 141-161, 1994 | 61 | 1994 |
The effects of administration of monoamine oxidase‐B inhibitors on rat striatal neurone responses to dopamine MD Berry, E Scarr, MY Zhu, IA Paterson, AV Juorio British journal of pharmacology 113 (4), 1159-1166, 1994 | 55 | 1994 |
Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders MD Berry Journal of Psychiatry and Neuroscience 29 (5), 337-345, 2004 | 49 | 2004 |
On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited A Holt, MD Berry, AA Boulton Neurotoxicology 25 (1-2), 251-266, 2004 | 48 | 2004 |
Prolongation of Life in an Experimental Model of Aging in Drosophila Melanogaster RG Jordens, MD Berry, C Gillott, AA Boulton Neurochemical research 24, 227-233, 1999 | 47 | 1999 |
Phosphorylation and Activation of Brain Aromatic l‐Amino Acid Decarboxylase by Cyclic AMP‐Dependent Protein Kinase AM Duchemin, MD Berry, NH Neff, M Hadjiconstantinou Journal of neurochemistry 75 (2), 725-731, 2000 | 43 | 2000 |
Membrane permeability of trace amines: Evidence for a regulated, activity‐dependent, nonexocytotic, synaptic release MD Berry, MR Shitut, A Almousa, J Alcorn, B Tomberli Synapse 67 (10), 656-667, 2013 | 38 | 2013 |
Trace amine-associated receptors as novel therapeutic targets for immunomodulatory disorders SL Christian, MD Berry Frontiers in Pharmacology 9, 361304, 2018 | 37 | 2018 |
Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases MD Berry, AA Boulton Neurotoxicology and teratology 24 (5), 667-673, 2002 | 27 | 2002 |
Loss of mitochondrial membrane potential is dependent on the apoptotic program activated: Prevention by R‐2HMP D Zhang, MD Berry, IA Paterson, AA Boulton Journal of neuroscience research 58 (2), 284-292, 1999 | 23 | 1999 |